The pandemic of coronavirus disease 2019 (COVID-19) has unique implications for the anesthetic management of endovascular therapy for acute ischemic stroke. The Society for Neuroscience in Anesthesiology and Critical Care appointed a task force to provide timely, consensus-based expert recommendations using available evidence for the safe and effective anesthetic management of endovascular therapy for acute ischemic stroke during the COVID-19 pandemic. The goal of this consensus statement is to provide recommendations for anesthetic management considering the following (and they are): (1) optimal neurological outcomes for patients; (2) minimizing the risk for health care professionals, and (3) facilitating judicious use of resources while accounting for existing variability in care. It provides a framework for selecting the optimal anesthetic technique (general anesthesia or monitored anesthesia care) for a given patient and offers suggestions for best practices for anesthesia care during the pandemic. Institutions and health care providers are encouraged to adapt these recommendations to best suit local needs, considering existing practice standards and resource availability to ensure safety of patients and providers.

中文翻译：

---

COVID-19 大流行期间急性缺血性中风血管内治疗的麻醉管理：麻醉与重症监护神经科学学会 (SNACC) 的共识声明：经血管与介入神经病学学会 (SVIN)、神经介入外科学会 (SNIS) 认可，神经重症监护学会 (NCS)、欧洲微创神经治疗学会 (ESMINT) 和美国神经外科医生协会 (AANS) 以及神经外科医生大会 (CNS) 脑血管分会。


2019 年冠状病毒病 (COVID-19) 的流行对急性缺血性卒中血管内治疗的麻醉管理具有独特的影响。麻醉学和重症监护神经科学学会任命了一个工作组，利用现有证据，及时提供基于共识的专家建议，以确保在 COVID-19 大流行期间对急性缺血性卒中的血管内治疗进行安全有效的麻醉管理。本共识声明的目标是为麻醉管理提供建议，考虑以下因素（它们是）：（1）患者的最佳神经学结果； (2) 最大限度地减少医疗保健专业人员的风险，以及 (3) 促进明智地使用资源，同时考虑到护理中现有的可变性。它提供了一个为特定患者选择最佳麻醉技术（全身麻醉或监测麻醉护理）的框架，并为大流行期间麻醉护理的最佳实践提供了建议。鼓励机构和医疗保健提供者考虑现有实践标准和资源可用性，调整这些建议以最适合当地需求，以确保患者和提供者的安全。